Auna (NYSE:AUNA) Stock Rating Lowered by Zacks Research

Key Points

• Zacks Research downgraded Auna (NYSE:AUNA) from a "strong-buy" to a hold rating in its latest report.
• Analyst views are mixed — one Strong Buy, one Buy, two Holds and one Sell — resulting in an average rating of Hold and an average price target of $7.30.
• Recent metrics: AUNA opened at $5.62 (12‑month range $4.46–$7.50) with a market cap of ~$416M; last quarter EPS was $0.53 on $596.6M revenue and analysts expect about 0.5 EPS for the current year.

Auna (NYSE:AUNA - Get Free Report) was downgraded by investment analysts at Zacks Research from a "strong-buy" rating to a "hold" rating in a report issued on Tuesday,Zacks.com reports.

Other analysts have also recently issued reports about the company. Wall Street Zen upgraded Auna from a "buy" rating to a "strong-buy" rating in a research report on Saturday, February 28th. HSBC raised Auna from a "hold" rating to a "buy" rating and set a $6.90 target price for the company in a research report on Wednesday, January 21st. Jefferies Financial Group initiated coverage on shares of Auna in a report on Friday, January 16th. They issued a "buy" rating and a $9.00 price target on the stock. Finally, Weiss Ratings restated a "sell (d)" rating on shares of Auna in a research note on Friday, March 27th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $7.30.

Auna Stock Up 2.0%

NYSE AUNA opened at $5.62 on Tuesday. Auna has a twelve month low of $4.46 and a twelve month high of $7.50. The stock has a market cap of $415.95 million, a PE ratio of 15.61 and a beta of 2.09. The firm has a 50-day simple moving average of $5.19 and a 200 day simple moving average of $5.35. The company has a debt-to-equity ratio of 1.87, a quick ratio of 1.01 and a current ratio of 1.11.

Auna (NYSE:AUNA - Get Free Report) last issued its quarterly earnings results on Saturday, February 14th. The company reported $0.53 earnings per share (EPS) for the quarter. The firm had revenue of $596.55 million for the quarter. Auna had a return on equity of 19.23% and a net margin of 2.13%. On average, research analysts forecast that Auna will post 0.5 EPS for the current year.

Institutional Trading of Auna

Several institutional investors have recently bought and sold shares of the stock. Goldman Sachs Group Inc. bought a new stake in Auna in the first quarter valued at $219,000. Hohimer Wealth Management LLC bought a new position in shares of Auna during the second quarter valued at $264,000. Sage Investment Counsel LLC acquired a new stake in shares of Auna in the 3rd quarter valued at $67,000. Virtu Financial LLC acquired a new stake in shares of Auna in the 3rd quarter valued at $75,000. Finally, Citadel Advisors LLC grew its holdings in shares of Auna by 28.9% in the 3rd quarter. Citadel Advisors LLC now owns 36,352 shares of the company's stock worth $244,000 after purchasing an additional 8,147 shares during the last quarter.

Auna Company Profile

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna's organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.